3D bioprinting technology
3D Printing Financials: How T&R BioFab is Balancing Innovation and Revenue Challenges
South Korean bioprinting pioneer T&R Biofab (Kosdaq: 246710) has been busy in recent months with new initiatives in regenerative medicine, collaborations, and product development. However, the company faces significant challenges…
Bioprinting’s Investment Milestones of 2023
Navigating through the landscape of bioprinting, 2023 unfolded as a year where targeted investments significantly nurtured this specialized field. The ripples of these investments indicate a maturing industry poised for…
Aspect Biosystems Strikes $2.6B Bioprinted Tissue Deal with Novo Nordisk
Bioprinting collaborations are heating up in 2023. In one of the biggest moves of the bioprinting industry, Canadian startup Aspect Biosystems and Danish pharma giant Novo Nordisk (CPH: NOVO-B) struck…
Systemic Bio Opens Bioprinting Lab to Accelerate Drug Discovery
3D Systems (NYSE: DDD) spinoff Systemic Bio opened a state-of-the-art laboratory to conduct research into hydrogel scaffold manufacturing and organ-on-a-chip as part of its mission to accelerate drug discovery and…
Inventia Life Science Opens its First U.S. Bioprinting Office in Delaware
Bioprinting machine manufacturer Inventia Life Science has opened its first U.S. office and facility at Delaware NGO The Innovation Space. The Sydney, Australia-based startup will benefit from the rich life…
Inventia Snags $3.2M in New Funding to Commercialize Bioprinter
After announcing a Series B round last January, Sydney-headquartered biotech startup Inventia received an additional AU$4.4 million ($3.2 million) from Australian pension fund giant HESTA. This latest investment brings Inventia’s…
BICO Buys Bioprinting Startup Allegro 3D—8th Acquisition in a Year
BICO (STO: BICO) has purchased another bioprinting startup, adding to its now massive portfolio of 13 acquisitions. This time around, it was rapid-throughput bioprinting company Allegro 3D, a spin-off from…
Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over
In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,…
Cellink Expands its Bioconvergence Footprint in India
Bioconvergence company Cellink partnered with 3D printing technology supplier Altem Technologies to accelerate the groundwork for life-sciences bioprinting in the Indian market. Local research institutions and hospitals can now contact…
Bioprinting Firm Cellink to Acquire 5th Company in 3 Years, In Vitro Firm MatTek
Just days after Cellink signed its latest acquisition agreement with global system supplier Ginolis, the company has announced a new takeover, this time of MatTek. A global leader of in…
REGENHU Unveils New Bioprinters, Software and More to Revamp Business
Innovative biomedical company REGENHU just launched its next-generation 3D bioprinters and software as part of its ongoing mission to revolutionize medicine. Called the R-GEN series, the new systems consolidate years…
Aspect Biosystems to Deliver Two Bioprinters to Researchers via New Grant Program
Pioneering microfluidic bioprinting company Aspect Biosystems launched a new grant program for research labs, enhancing the use of 3D bioprinting technology. The Vancouver-based biotechnology firm will choose two winners that…
What It Takes to Design a Bioprinter for Cancer Research, from Inventia Life Sciences
At a time when experts predict cancer will remain a massive health problem, advances in technology can make a big difference. Earlier this year, the World Health Organization (WHO) announced…
Cellink Teams with Lonza to Advance Bioprinting Cell Cultures
For over four years biotech company Cellink has been helping researchers pursue creative ways to promote organ regeneration, test novel drugs, develop vascularized bioconstructs, and more. Through collaborative partnerships and…
UNICAEN: New Bioprinted Tumor Models Help Researchers in France Study Its Biology
Studying cancer biology is among the top priorities for researchers around the world. From consortiums to universities, pharma companies, newcomers in the drug development industry, and research institutions, current research…
OxSyBio Raises £10 Million in Series A Financing for 3D Bioprinting Platform to Solve Donor Organ Shortage
In the field of 3D bioprinting, the major, overarching goal is to be able to fabricate functional 3D printed human organs. Many bioprinting companies, such as Organovo and Aether, are making…
BASF & CTIBiotech: Bioprinting Expands to the Sebaceous Glands
If you are starting to get the impression that there is little researchers and innovators cannot do with 3D printing, you are thinking in the right direction—as are so many…